EpimAb Biotherapeutics
ID: 5869453EpimAb Biotherapeutics is a bi-specific Antibodies founded in 2015 by Chengbin Wu.
2
Funding Rounds
$99.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ch****** Wu | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Vi**** To** | - | - | linkedin twitter instagram |
Funding series
Funding Series Analysis
The company EpimAb Biotherapeutics has raised a total of $74m in funding over 2 rounds.
Key Insights:
- EpimAb Biotherapeutics Series B round, June 2019: $74m
- EpimAb Biotherapeutics funding round, April 2017: $25m
Industries
EpimAb Biotherapeutics is active in the following industries: